GO:0006714 sesquiterpenoid metabolic process: Biosynthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006714 sesquiterpenoid metabolic process describes the cellular and biochemical reactions that produce, modify, and interconvert sesquiterpenoids, a vast class of 15-carbon terpenoid natural products.
• Sesquiterpenoids are built from the universal C15 precursor farnesyl diphosphate (FPP) and diversified by terpene synthases and cytochrome P450-mediated oxidations.
• These pathways yield molecules with anti-inflammatory, antimalarial, and anticancer activities, making them high-value targets for drug discovery.
• Metabolic engineering of sesquiterpenoid pathways is powerful but prone to unspecific side reactions that require careful enzyme characterization.
• Dimeric sesquiterpenoids represent a structurally complex subclass generated by coupling reactions, with emerging pharmacological relevance.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in sesquiterpenoid metabolism.
Description
Sesquiterpenoid metabolic process (GO:0006714) is a biological process that encompasses the enzymatic reactions and pathways responsible for the biosynthesis, modification, and interconversion of sesquiterpenoids, a large and structurally diverse family of 15-carbon terpenoid natural products. These compounds are derived from the universal C15 precursor farnesyl diphosphate (FPP) and are elaborated by terpene synthases and downstream tailoring enzymes such as cytochrome P450s. The process is central to plant, fungal, and some marine organism chemical ecology, and it produces molecules with potent anti-inflammatory, antimalarial, and anticancer activities. For researchers, GO:0006714 provides a controlled vocabulary to annotate genes and pathways involved in sesquiterpenoid biosynthesis, enabling comparative genomics, metabolic engineering, and drug discovery. The pathway's complexity, including rearrangement-competent oxidation levels and dimerization events, makes it a rich subject for mechanistic and synthetic biology studies. Understanding this process at the gene and enzyme level is essential for harnessing sesquiterpenoids as pharmaceuticals and for dissecting their roles in plant defense and human health.
sesquiterpenoid metabolic process At A Glance
| GO ID | GO:0006714 |
|---|---|
| GO term | sesquiterpenoid metabolic process |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Biosynthesis, modification, and interconversion of 15-carbon terpenoids (sesquiterpenoids) from farnesyl diphosphate and related precursors |
| Representative enzymes | Terpene synthases, cytochrome P450 monooxygenases, oxidoreductases, transferases |
| Key precursor | Farnesyl diphosphate (FPP) |
| Taxonomic scope | Plants, fungi, and some marine organisms |
| Related processes | Terpenoid biosynthetic process, sesquiterpene biosynthetic process, oxidation-reduction process |
What Is GO:0006714?
In our own words, GO:0006714 sesquiterpenoid metabolic process refers to the set of biochemical reactions and pathways by which living organisms synthesize, modify, and break down sesquiterpenoids, a class of terpenoids containing 15 carbon atoms. This includes the cyclization of farnesyl diphosphate into diverse sesquiterpene scaffolds, subsequent oxidations, rearrangements, and dimerizations that generate the enormous structural diversity observed in nature.
Why Is sesquiterpenoid metabolic process Important in Cell Biology?
GO:0006714 is important because sesquiterpenoids constitute one of the largest and most structurally diverse classes of natural products, many of which have significant pharmacological value. The pathway produces anti-inflammatory agents, antimalarial compounds, and anticancer leads, and it is a major source of molecules for drug discovery and metabolic engineering. Understanding the genes and enzymes of this process enables rational design of microbial or plant cell factories for sustainable production of high-value sesquiterpenoids.
• Sesquiterpenoids include clinically relevant anti-inflammatory compounds, such as those from Ligularia fischeri.
• Antimalarial eudesmane sesquiterpenoids from Dobinea delavayi highlight the pathway's potential for antiparasitic drug development.
• Dimeric guaianolide sesquiterpenoids from Chrysanthemum indicum ameliorate hepatic steatosis, linking the pathway to metabolic disease.
• Gossypol, a sesquiterpenoid phytoalexin from cotton, plays a role in plant defense and has been studied for its biological activities.
• Metabolic engineering of sesquiterpenoid pathways can be hampered by unspecific reactions, making enzyme specificity a key research focus.
• Predicting rearrangement-competent oxidation levels aids in understanding sesquiterpenoid structural diversification.
• Dimeric sesquiterpenoids are a growing subclass with complex structures and emerging bioactivities.
• The pathway is a model for studying terpenoid cyclization mechanisms and enzyme evolution.
• CRISPR-based models allow functional validation of candidate genes in sesquiterpenoid metabolism.
• Sesquiterpenoid metabolic process is relevant to agriculture, biotechnology, and human health.
What Happens During sesquiterpenoid metabolic process?
Formation of the C15 precursor farnesyl diphosphate
In simple terms: The cell first builds a 15-carbon molecule called farnesyl diphosphate, which is the starting material for all sesquiterpenoids.
Sesquiterpenoid biosynthesis begins with the generation of farnesyl diphosphate (FPP) through the mevalonate or methylerythritol phosphate pathways. FPP serves as the universal C15 precursor that is subsequently cyclized by terpene synthases. The availability of FPP is a key metabolic node that influences flux into sesquiterpenoid production.
Cyclization by terpene synthases
In simple terms: Enzymes called terpene synthases fold the 15-carbon chain into rings, creating the initial sesquiterpene skeletons.
Terpene synthases catalyze the cyclization of FPP into a wide array of sesquiterpene scaffolds, including eudesmane, guaianolide, and other skeletal types. These enzymes are responsible for the initial structural diversification and often exhibit complex rearrangement chemistry. The specificity of terpene synthases is critical for directing flux toward desired products.
Oxidative tailoring and rearrangement
In simple terms: After the rings are formed, oxidation reactions add oxygen atoms and can trigger rearrangements that further modify the molecules.
Cytochrome P450 monooxygenases and other oxidoreductases introduce oxygen functionalities and catalyze oxidative rearrangements, leading to the vast chemical diversity of sesquiterpenoids. Predicting rearrangement-competent oxidation levels is an active area of research to understand how structural complexity arises. Unspecific oxidation reactions can be a pitfall in metabolic engineering, necessitating careful enzyme selection.
Dimerization and further modifications
In simple terms: Some sesquiterpenoids are joined together to form larger dimeric molecules, which can have enhanced or new biological activities.
Dimeric sesquiterpenoids are formed through coupling reactions, often involving radical or oxidative mechanisms, resulting in complex structures such as disesquiterpenoids. These dimeric compounds have been increasingly recognized for their pharmacological potential, including anti-inflammatory and anticancer activities. The enzymes and mechanisms responsible for dimerization are still being elucidated.
Biological roles and accumulation
In simple terms: The final sesquiterpenoids serve various roles in the organism, such as defense against pests or pathogens, and can accumulate in specific tissues.
Sesquiterpenoids function as phytoalexins, antimicrobial agents, and signaling molecules in plants. For example, gossypol in cotton acts as a phytoalexin against pathogens. In humans, dietary or medicinal sesquiterpenoids can modulate pathways related to inflammation and lipid metabolism. The accumulation of these compounds is often tissue-specific and developmentally regulated.
Key Genes Involved in GO:0006714 sesquiterpenoid metabolic process
The following genes and enzymes are representative of those involved in sesquiterpenoid metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FPS1 | Farnesyl diphosphate synthase; produces FPP precursor | Target for flux control in sesquiterpenoid engineering |
| TPS1 | Terpene synthase; cyclizes FPP to sesquiterpene scaffolds | Key for structural diversity and pathway specificity |
| CYP71 | Cytochrome P450; oxidative tailoring | Introduces oxygen and catalyzes rearrangements |
| SIRT1 | Deacetylase; modulates lipid accumulation and ferroptosis | Implicated in sesquiterpenoid-mediated amelioration of hepatic steatosis |
| GOS | Gossypol biosynthesis; phytoalexin production | Model for plant defense sesquiterpenoids |
| LFS | Sesquiterpenoid biosynthesis in Ligularia fischeri | Source of anti-inflammatory sesquiterpenoids |
| DOD | Eudesmane sesquiterpenoid biosynthesis in Dobinea delavayi | Antimalarial compound production |
| CIS | Dimeric guaianolide biosynthesis in Chrysanthemum indicum | Hepatic steatosis model |
| HMGR | Mevalonate pathway enzyme; upstream of FPP | Regulates precursor supply |
| DXS | MEP pathway enzyme; alternative route to FPP | Contributes to precursor pool |
| ACT | Acyltransferase; possible modification | Potential tailoring enzyme |
| GT | Glycosyltransferase; possible modification | Diversifies sesquiterpenoid structures |
| OXR | Oxidoreductase; redox tailoring | Affects oxidation levels and rearrangements |
| DIM | Dimerization enzyme or factor | Generates dimeric sesquiterpenoids |
| PAL | Phenylalanine ammonia-lyase; links to phenylpropanoid pathway | Cross-talk with other defense pathways |
| MYB | Transcription factor; regulates sesquiterpenoid biosynthesis | Controls pathway gene expression |
| WRKY | Transcription factor; stress-responsive regulation | Modulates sesquiterpenoid production |
| JAZ | Jasmonate ZIM-domain; repressor of jasmonate signaling | Regulates defense-related sesquiterpenoid genes |
How Is sesquiterpenoid metabolic process Regulated?
Sesquiterpenoid metabolic process is regulated at multiple levels, including transcriptional control by MYB and WRKY transcription factors, post-translational regulation of enzymes, and feedback inhibition by pathway intermediates. Jasmonate signaling, mediated by JAZ repressors, plays a central role in inducing sesquiterpenoid biosynthesis in response to stress. In metabolic engineering, unspecific reactions and flux imbalances can disrupt regulation, highlighting the need for precise control.
sesquiterpenoid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIRT1 | Hepatic steatosis; lipid accumulation and ferroptosis | SIRT1 knockout or overexpression in hepatocytes |
| GOS | Plant defense; phytoalexin activity | Cotton cell cultures or transgenic plants |
| LFS | Inflammation | Macrophage or neutrophil models treated with sesquiterpenoids |
| DOD | Malaria | Plasmodium falciparum cultures with sesquiterpenoid treatment |
| CIS | Metabolic syndrome | Mouse models of diet-induced obesity |
Sesquiterpenoids in hepatic steatosis and metabolic disease
Dimeric guaianolide sesquiterpenoids from Chrysanthemum indicum have been shown to ameliorate hepatic steatosis by mitigating SIRT1-mediated lipid accumulation and ferroptosis. This links sesquiterpenoid metabolic process to metabolic disorders and suggests that modulating this pathway could have therapeutic potential for fatty liver disease.
Anti-inflammatory and antimalarial applications
Sesquiterpenoids from Ligularia fischeri exhibit anti-inflammatory activities, while eudesmane sesquiterpenoids from Dobinea delavayi show antimalarial effects. These findings underscore the pharmacological relevance of the pathway and support drug discovery efforts targeting sesquiterpenoid biosynthesis.
Cancer and chemoprevention
Dimeric sesquiterpenoids and disesquiterpenoids have been investigated for anticancer properties, with some compounds showing cytotoxic activity against cancer cell lines. The structural complexity of these molecules makes them attractive leads for chemoprevention and therapy.
From sesquiterpenoid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of a terpene synthase reduce sesquiterpenoid production? | CRISPR knockout in plant or fungal cells |
| Can a point mutation alter enzyme specificity? | CRISPR point mutation knock-in |
| Does overexpression of FPS1 increase flux to sesquiterpenoids? | CRISPR overexpression or promoter knock-in |
| How does SIRT1 modulation affect sesquiterpenoid-mediated lipid accumulation? | SIRT1 knockout or overexpression in hepatocytes |
| Can dimerization be enhanced by knocking in a coupling enzyme? | CRISPR knock-in of dimerization gene |
| What is the role of a transcription factor in regulating the pathway? | CRISPR knockout of MYB or WRKY |
How to Study the sesquiterpenoid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS | Sesquiterpenoid profiles and quantities | Metabolite identification and flux analysis |
| GC-MS | Volatile sesquiterpenoids | Headspace analysis of plant volatiles |
| RNA-seq | Transcript levels of pathway genes | Gene discovery and expression profiling |
| qPCR | Expression of specific genes | Validation of RNA-seq results |
| Enzyme assay | Catalytic activity and substrate specificity | Characterization of terpene synthases |
| CRISPR knockout | Loss-of-function phenotypes | Gene function validation |
| CRISPR knock-in | Precise mutations or tags | Structure-function studies |
| Metabolic engineering | Production titers in heterologous hosts | Pathway optimization |
Metabolomics and analytical chemistry
Metabolomic profiling using LC-MS and GC-MS is essential to identify and quantify sesquiterpenoids produced in cells or organisms. These methods allow researchers to track pathway flux and detect novel compounds.
Transcriptomics and gene expression analysis
RNA-seq and qPCR are used to measure expression of terpene synthases, cytochrome P450s, and transcription factors involved in sesquiterpenoid metabolism. Co-expression analysis can identify candidate genes in the pathway.
Enzyme assays and biochemical characterization
In vitro enzyme assays with recombinant proteins are used to determine substrate specificity, kinetic parameters, and product profiles of terpene synthases and tailoring enzymes. These assays help predict rearrangement-competent oxidation levels.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and overexpression screens enable systematic testing of gene function in sesquiterpenoid metabolism. These approaches can identify essential genes and regulatory nodes.
How CRISPR Can Be Used to Study GO:0006714 sesquiterpenoid metabolic process
Knockout
CRISPR knockout is used to disrupt genes encoding terpene synthases, cytochrome P450s, or regulatory factors to assess their role in sesquiterpenoid production. For example, knocking out SIRT1 can test its involvement in sesquiterpenoid-mediated lipid accumulation.
Point Mutation
Point mutations can be introduced to alter enzyme active sites, affecting substrate specificity or catalytic efficiency. This is particularly useful for studying rearrangement-competent oxidation levels and unspecific reactions.
Knock-in
Knock-in of tagged or modified genes allows tracking of enzyme localization and interactions, or introduction of dimerization domains to study dimeric sesquiterpenoid formation. It can also be used to insert promoter elements for overexpression.
Overexpression
CRISPR activation or promoter knock-in can overexpress rate-limiting enzymes such as FPS1 to increase flux through the sesquiterpenoid pathway. Overexpression of transcription factors like MYB can also boost pathway gene expression.
How EDITGENE Supports sesquiterpenoid metabolic process Research
Researchers studying sesquiterpenoid metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolite production, disease modulation, or stress responses. EDITGENE provides CRISPR-based cell models and screening services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for sesquiterpenoid metabolic process research.
Frequently Asked Questions About sesquiterpenoid metabolic process
What is GO:0006714 sesquiterpenoid metabolic process?
GO:0006714 is a Gene Ontology biological process term describing the cellular reactions that synthesize, modify, and interconvert sesquiterpenoids, a class of 15-carbon terpenoid natural products.
What genes are involved in sesquiterpenoid metabolic process?
Key genes include terpene synthases (e.g., TPS1), cytochrome P450s (e.g., CYP71), farnesyl diphosphate synthase (FPS1), and transcription factors such as MYB and WRKY.
What is the precursor for sesquiterpenoid biosynthesis?
Farnesyl diphosphate (FPP) is the universal C15 precursor for all sesquiterpenoids.
How are sesquiterpenoids classified?
They are classified by their carbon skeletons, such as eudesmane, guaianolide, and germacrane, which arise from different cyclization modes of FPP.
What are dimeric sesquiterpenoids?
Dimeric sesquiterpenoids are compounds formed by coupling two sesquiterpene units, often exhibiting enhanced or novel bioactivities.
Why is sesquiterpenoid metabolic process important for drug discovery?
Many sesquiterpenoids have anti-inflammatory, antimalarial, and anticancer activities, making the pathway a rich source of therapeutic leads.
How can CRISPR be used to study sesquiterpenoid metabolism?
CRISPR knockout, knock-in, and overexpression can validate gene function, alter enzyme specificity, and engineer pathways for increased production.
What is the role of SIRT1 in sesquiterpenoid metabolism?
SIRT1 is involved in mediating the effects of dimeric guaianolide sesquiterpenoids on lipid accumulation and ferroptosis in hepatic steatosis.
What are common pitfalls in sesquiterpenoid metabolic engineering?
Unspecific reactions and flux imbalances can lead to unwanted products, requiring careful enzyme selection and pathway regulation.
Which organisms produce sesquiterpenoids?
Plants, fungi, and some marine organisms produce sesquiterpenoids, often as defense compounds or signaling molecules.
Conclusion
GO:0006714 sesquiterpenoid metabolic process is a fundamental biological process that generates a vast array of structurally diverse natural products with significant pharmacological potential. Understanding its genes, enzymes, and regulation is essential for drug discovery and metabolic engineering. CRISPR-based models and advanced analytical methods are accelerating research in this field, enabling precise functional studies and pathway optimization.
References
- 1. Ma LF et al.. 2020. Natural disesquiterpenoids: an update.. Nat Prod Rep 37(7):999-1030 PMID: 32104815
- 2. Liu Y et al.. 2025. Dimeric guaianolide sesquiterpenoids from the flowers of Chrysanthemum indicum ameliorate hepatic steatosis through mitigating SIRT1-mediated lipid accumulation and ferroptosis.. J Adv Res 76:345-370 PMID: 39788286
- 3. Liao SG et al.. 2016. Dimeric Sesquiterpenoids.. Prog Chem Org Nat Prod 101:1-112 PMID: 26659108
- 4. Tian X et al.. 2016. Gossypol: phytoalexin of cotton.. Sci China Life Sci 59(2):122-9 PMID: 26803304
- 5. Zhai B et al.. 2024. Anti-inflammatory sesquiterpenoids from Ligularia fischeriTurcz.. Fitoterapia 177:106088 PMID: 38897245
- 6. McCulley CH et al.. 2020. Predicting Rearrangement-Competent Terpenoid Oxidation Levels.. J Am Chem Soc 142(13):6060-6065 PMID: 32157874
- 7. Frey M. 2020. Traps and Pitfalls-Unspecific Reactions in Metabolic Engineering of Sesquiterpenoid Pathways.. Molecules 25(8) PMID: 32331245
- 8. Shen Y et al.. 2020. Antimalarial Eudesmane Sesquiterpenoids from Dobinea delavayi.. J Nat Prod 83(4):927-936 PMID: 32233487
